Aldosterone antagonism in an inflammatory state: Evidence for myocardial protection

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 7, Issue 3, 2006, Pages 162-167

  Ramirez, Felix J A ^a   Salemi, Vera M C ^a   Ianni, Barbara M ^a   Fernandez, Fábio ^a   Martins, Daniel G ^a   Billate, Angelina ^a   Neto, Edécio Cunha ^a   Mady, Charles ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Animal models; Cardiomyopathy; Fibrosis; Renin angiotensin system; Ventricular function

Indexed keywords

SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; DRUG RESPONSE; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART PROTECTION; HEART VENTRICLE REMODELING; INFLAMMATORY INFILTRATE; MORTALITY; NONHUMAN; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SYRIAN HAMSTER; TRYPANOSOMA CRUZI;

EID: 33750983621     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2006.026     Document Type: Article

References (32)

1. Guhl F, Jaramillo C, Yockteng R, Vallejo GA, Cardenas-Arroyo F. Trypanosoma cruzi DNA in human mummies. Lancet 1997;349:1370 (letter).
2. Schmunis GA, Zicker F, Moncayo A. Interruption of Chagas' disease transmission through vector elimination. Lancet 1996;348:1171 (letter).
3. Unverferth DV, Fetters JK, Unverferth BJ et al. Human myocardial histologic characteristics in congestive heart failure. Circulation 1983;68:1194-200.
4. Mady C, Ianni BM, Arteaga E et al. Relation between interstitial myocardial collagen and the degree of clinical impairment in Chagas' disease. Am J Cardiol 1999;84:354-6.
5. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002;18:262-5.
6. Cunha-Neto E, Rizzo LV, Albuquerque F et al. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res 1998;31:133-7.
7. Mengel JO, Rossi MA. Chronic chagasic myocarditis pathogenesis: dependence on autoimmune and microvascular factors. Am Heart J 1992;124:1052-7.
8. Leon JS, Engman DM. Autoimmunity in Chagas heart disease. Int J Parasitol 2001;31:555-61.
9. Higuchi ML, Benvenuti LA, Reis MM, Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003;60:96-107.
10. Ramires FJ, Sun Y, Weber KT. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade. J Mol Cell Cardiol 1998;30:475-83.
11. Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995;269:E657-E662.
12. Farivar RS, Crawford DC, Chobanian AV, Brecher P. Effect of angiotensin II blockade on proliferative response to phenylephrine in the rat heart. Hypertension 1995;25:809-13.
13. Brilla CG, Rupp H, Funck R, Maisch B. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 1995;16(suppl O):107-09.
14. Funder JW. Aldosterone, mineralocorticoid receptors and vascular inflammation. Mol Cell Endocrinol 2004;217:263-9.
15. Weber KT. A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism. Herz 2003;28: 692-701.
16. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Alclactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
17. Bilate AM, Salemi VM, Ramires FJ et al. The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis. Microbes Infect 2003;5:1116-24.
18. Salemi VM, Bilate AM, Ramires FJ et al. Reference values from M-mode and Doppler echocardiography for normal Syrian hamsters. Eur J Echocardiogr 2005;6(1):41-6.
19. Sun Y, Ratajska A, Weber KT. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J Lab Clin Med 1995;126:95-101.
20. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987;18:619-24.
21. Ramires O, Mansur A, Coelho O et al. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 2000;85:1207-11.
22. Wang D, Liu YH, Yang XP et al. Role of a selective aldosterone blocker in mice with chronic heart failure. J Card Fail 2004;10:67-73.
23. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 2004;217:53-8.
24. Campbell SE, Janicki JS, Weber KT. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 1995;27:1545-60.
25. Klauber N, Browne F, Anand-Apte B, D'Amato RJ. New activity of spironolactone inhibition of angiogenesis in vitro and in vivo. Circulation 1996;94:2566-71.
26. Ahokas RA, Warrington KJ, Gerling IC. Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. Circ Res 2003;93:e124-e135.
27. Lu L, Chen SS, Zhang JQ, Ramires FJA, Sun Y. Activation of nuclear factor-β and its proinflammatory mediator cascade in the infarcted rat heart. Biochem Biophys Res Commun 2004;321:879-85.
28. Weber KT. From inflammation to fibrosis: a stiff stretch of highway. Hypertension 2004;43:716-19.
29. Waghabi MC, Coutinho CM, Soeiro MN et al. Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin. Infect Immun 2002;70:5115-23.
30. Carrasco Guerra HA, Palacios-Pru E, Dagert de Scorza C, Molina C, Inglessis G, Mendoza RV. Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of early myocardial damage. Am Heart J 1987;113:716-24.
31. Palomino SA, Aiello VD, Higuchi ML. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 2000;94:571-9.
32. Higuchi ML, Brito T, Reis MM et al. Correlation between T. cruzi parasitism and myocardial inflammation in human chronic chagasic myocarditis. Light microscopy and immunohistochemical findings. Cardiovasc Patbol 1993;2: 101-06.